| Literature DB >> 35706082 |
Zahra Hashemizadeh1, Gholamreza Hatam2, Javad Fathi1,3, Fatemeh Aminazadeh1, Hossein Hosseini-Nave4, Mahtab Hadadi1, Nafiseh Hosseinzadeh Shakib1, Sodeh Kholdi1, Abdollah Bazargani5.
Abstract
BACKGROUND: Acinetobacter baumannii is one of the most important hospital pathogenic bacteria that cause infectious diseases. The present study aimed to determine the frequency of carbapenem resistance genes in association with transposable elements and molecular typing of carbapenem-resistant A. baumannii bacteria collected from patients in Shiraz, Iran.Entities:
Keywords: Acinetobacter baumannii; Carbapenem-resistant A. baumannii; Insertion sequence; OXA Carbapenemase; Transposon
Year: 2022 PMID: 35706082 PMCID: PMC9259918 DOI: 10.3947/ic.2022.0022
Source DB: PubMed Journal: Infect Chemother ISSN: 1598-8112
The primers used in this study
| Primer name | Primer sequence | Target | Reference |
|---|---|---|---|
| OXA51-F | TAA TGC TTT GAT CGG CCT TG | OXA51 | [ |
| OXA51-R | TGG ATT GCA CTT CAT CTT GG | ||
| OXA58-F | AAG TAT TGG GGC TTG TGC TG | OXA58 | [ |
| OXA58-R | CCC CTC TGC GCT CTA CAT AC | ||
| OXA23-F | GAT CGG ATT GGA GAA CCA | OXA23 | [ |
| OXA23-R | ATT TCT GAC CGC ATT TCC AT | ||
| OXA24-F | GGT TAG TTG GCC CCC TTA AA | OXA24 | [ |
| OXA24-R | AGT TGA GCG AAA AGG GGA TT | ||
| IS | AGGCTATAAAGCGTTGA | IS | [ |
| Oxa51-R | CTTCTGTGGTGGTTGC | ||
| IS | AACGATTGCGAGCATC | IS | [ |
| OXA23-R | GTCAACCAGCCCACTT | ||
| IS | ATGCAGCGCTTCTTTGCCAGGCGA | IS | [ |
| IS | AATGATTGGTGACAATGAAG | ||
| IS | AATCCGAGATAGAGCGGTTC | IS | [ |
| IS | TGACACATAACCTAGTGCAC | ||
| IS | CAATCAAATGTCCAACCTGC | IS | [ |
| IS | CGTTTACCCCAAACATAAGC | ||
| IS | ATTTGAACCCATCTATTGGC | IS | [ |
| IS | ACTCTCATATTTTTTCTTGG | ||
| IS | CACCCAACTTTCTCAAGATG | IS | [ |
| IS | ACCAGCCATAACTTCACTCG | ||
| P3 | GTCTATCAGGAACTTGCGCG | Tn2008 | [ |
| P5 | GGCTCATTACAGTCAGGTACAAGT | ||
| P4 | GCAAGGCTTTAGATGCAGAAGA | Tn2006 | [ |
| P3 | GTCTATCAGGAACTTGCGCG | ||
| P1 | ATCCTGATGCTCGCAATCGT | Tn2009 | [ |
| P8 | CTGTCTGCGAACACATTCAC | ||
| P6 | ATTTGAACCCATCTATTGGC | Tn2007 | [ |
| P7 | ACTCTCATATTTTTTCTTGG | ||
| F-GGAATAGAGTGGCTTAAYTCTC | IMP | [ | |
| R-GGTTTAAYAAAACAACCACC | |||
| F-ATGTTAAAAGTTATTAGTAGT | VIM | [ | |
| R-CTACTCGGCGACTGAGCGAT | |||
| F-TCGACACACCTTGGTCTGAA | GIM | [ | |
| R-AACTTCCAACTTTGCCATGC | |||
| F-TACAAGGGATTCGGCATCG | SIM | [ | |
| R-TAATGGCCTGTTCCCATGTG | |||
| F-ATGCGCTTCATTCACGCAC | GES | [ | |
| R-CTATTTGTCCGTGCTCAGG | |||
| F-AAAATCTGGGTACGCAAACG | SPM | [ | |
| R-ACATTATCCGCTGGAACAGG | |||
| F-GGTTTGGCGATCTGGTTTTC | NDM | [ | |
| R-CGGAATGGCTCATCACGATC | |||
| F-TCTGGACCGCTGGGAGCTGG | KPC | [ | |
| R-TCGCCGTTGACGCCCAATCC |
IMP, imipenemase; VIM, verona Integron-encoded metallo-beta-lactamase; GIM, German imipenemase; SIM, Seoul imipenemase; GES, Guiana extended spectrum; SPM, São Paulo metallo-beta-lactamase; NDM, New Delhi metallo-beta-lactamase; KPC, Klebsiella pneumoniae carbapenemase.
Demographic and clinical characteristics of the Acinetobacter baumannii isolates
| Characteristic | No (%) | |
|---|---|---|
| Age range | 5 – 82 | |
| Gender | M (95, 55.8%), | |
| F (75, 44.2%) | ||
| Type of specimen | ||
| Sputum | 72 (42.3) | |
| Blood | 20 (11.7) | |
| Tracheal | 8 (4.7) | |
| Urine | 8 (4.7) | |
| ETT | 30 (17.6) | |
| Tip catheter | 3 (1.7) | |
| Pleural | 6 (3.5) | |
| CSF | 1 (0.6) | |
| Wound | 12 (7) | |
| Nasal | 1 (0.6) | |
| Abscess | 1 (0.6) | |
| Throat | 4 (2.3) | |
| Auxiliary | 1 (0.6) | |
| Fluid | 2 (1.2) | |
| Abdominal | 1 (0.6) | |
| Ward | ||
| ICU | 87 (51.2) | |
| Internal | 39 (23) | |
| Surgery | 15 (8.8) | |
| Emergency | 25 (14.7) | |
| Infant | 1 (0.6) | |
| Infection | 2 (1.2) | |
| Oncology | 1 (0.6) | |
M, male; F, female; ETT, endotracheal tube; CSF, cerebrospinal fluid; ICU, intensive care unit.
Co-existence of OXA-type carbapenemase, MBLS genes, and IS elements among Acinetobacter bumannii isolates
| Genes | Number of isolates No. (%) |
|---|---|
| 22 (12.9) | |
| 22 (12.9) | |
| 1 (0.6) | |
| 2 (1.17) | |
| 2 (1.17) | |
| 1 (0.6) | |
| 1 (0.6) | |
| 1 (0.6) | |
| 68 (40) | |
| 5 (2.9) | |
| 92 (54.1) | |
| 4 (2.35) | |
| 51 (30) | |
| 16 (9.4) | |
| 1 (0.6) | |
| 16 (9.4) | |
| 48 (28.2) | |
| 18 (10.6) |
Distribution of class D lactamase genes-insertion sequences and transposons in Acinetobacter baumannii isolates
| Class D and its insertion sequences | Transposons | Number of isolates (%) | |
|---|---|---|---|
| IS | TN2008 | 5 (3) | 0.1 |
| IS | TN2006 | 40 (23.5) | 0.1 |
| IS | TN2007 | 2 (1.2) | 0.1 |
| IS | TN2009 | 63 (37) | 0.1 |
| IS | TN2008 | 39 (23) | 0.0001 |
| IS | TN2006 | 36 (21.1) | 0.0001 |
| IS | TN2007 | 2 (1.2) | 0.1 |
| IS | TN2009 | 57 (33.5) | 0.0001 |
| IS | TN2008 | 21 (12.3) | 0.005 |
| IS | TN2006 | 17 (10) | 0.02 |
| IS | TN2009 | 23 (13.5) | 0.0001 |
| IS | TN2008 | 4 (2.35) | 0.2 |
| IS | TN2006 | 3 (2) | 0.3 |
| IS | TN2009 | 5 (3) | 0.1 |
| IS | TN2008 | 3 (2) | 0.3 |
| IS | TN2006 | 3 (2) | 0.3 |
| IS | TN2009 | 5 (3) | 0.1 |
| IS | TN2008 | 3 (2) | 0.1 |
| IS | TN2006 | 3 (2) | 0.1 |
| IS | TN2009 | 5 (3) | 0.01 |
| IS | TN2008 | 1 (0.6) | 0.5 |
| IS | TN2006 | 1 (0.6) | 0.5 |
| IS | TN2009 | 1 (0.6) | 0.5 |
| IS | TN2008 | 3 (2) | 0.2 |
| IS | TN2006 | 3 (2) | 0.2 |
| IS | TN2009 | 5 (3) | 0.1 |
| IS | TN2008 | 1 (0.6) | 0.1 |
| IS | TN2009 | 1 (0.6) | 0.1 |
| IS | TN2009 | 1 (0.6) | 0.5 |
| IS | TN2008 | 1 (0.6) | 0.5 |
| IS | TN2008 | 1 (0.6) | 0.2 |
| IS | TN2009 | 1 (0.6) | 0.1 |
| IS | TN2008 | 2 (1.2) | 0.1 |
| IS | TN2006 | 2 (1.2) | 0.1 |
| IS | TN2009 | 3 (2) | 0.1 |
| IS | TN2008 | 2 (1.2) | 0.05 |
| IS | TN2006 | 2 (1.2) | 0.05 |
| IS | TN2009 | 3 (2) | 0.006 |
| IS | TN2008 | 1 (0.6) | 0.5 |
| IS | TN2009 | 1 (0.6) | 0.5 |
Figure 1Dendrogram of 24 Acinetobacter baumannii isolates with blaOXA-23-like, blaOXA-24-like, and ISAB1 genes based on ERIC-PCR patterns.
ERIC-PCR, enterobacterial repetitive intergenic consensus-polymerase chain reaction; G, gender; M, male, F, female; N, Namazi hospital; F, Faghihi hospital; ICU, Intensive care unit; ETT, endotracheal tube specimens; VIM, Verona integron-encoded; OXA, oxacillin; GES, Guiana extended spectrum; SPM, São Paulo metallo-beta-lactamase.